Kumada H - Search Results

1

Effects of branched-chain amino acid granules on serum albumin level and prognosis are dependent on treatment adherence in patients with liver cirrhosis.

Takaguchi K, Moriwaki H, Doyama H, Iida M, Yagura M, Shimada N, Kang M, Yamada H, Kumada H. Takaguchi K, et al. Among authors: kumada h. Hepatol Res. 2013 May;43(5):459-66. doi: 10.1111/j.1872-034X.2012.01097.x. Epub 2012 Oct 10. Hepatol Res. 2013. PMID: 23046471 Free PMC article.

2

Efficacy of lamivudine for preventing hepatocellular carcinoma in chronic hepatitis B: A multicenter retrospective study of 2795 patients.

Matsumoto A, Tanaka E, Rokuhara A, Kiyosawa K, Kumada H, Omata M, Okita K, Hayashi N, Okanoue T, Iino S, Tanikawa K; Inuyama Hepatitis Study Group. Matsumoto A, et al. Among authors: kumada h. Hepatol Res. 2005 Jul;32(3):173-84. doi: 10.1016/j.hepres.2005.02.006. Epub 2005 Jul 18. Hepatol Res. 2005. PMID: 16024289

3

Effects of oral branched-chain amino acid granules on event-free survival in patients with liver cirrhosis.

Muto Y, Sato S, Watanabe A, Moriwaki H, Suzuki K, Kato A, Kato M, Nakamura T, Higuchi K, Nishiguchi S, Kumada H; Long-Term Survival Study Group. Muto Y, et al. Among authors: kumada h. Clin Gastroenterol Hepatol. 2005 Jul;3(7):705-13. doi: 10.1016/s1542-3565(05)00017-0. Clin Gastroenterol Hepatol. 2005. PMID: 16206505 Clinical Trial.

4

Timing of interferon therapy and sources of infection in patients with acute hepatitis C.

Ogata K, Ide T, Kumashiro R, Kumada H, Yotsuyanagi H, Okita K, Akahane Y, Kaneko S, Tsubouchi H, Tanaka E, Moriwaki H, Nishiguchi S, Kakumu S, Mizokami M, Iino S, Sata M. Ogata K, et al. Among authors: kumada h. Hepatol Res. 2006 Jan;34(1):35-40. doi: 10.1016/j.hepres.2005.08.012. Epub 2005 Dec 15. Hepatol Res. 2006. PMID: 16359917

5

Overweight and obesity increase the risk for liver cancer in patients with liver cirrhosis and long-term oral supplementation with branched-chain amino acid granules inhibits liver carcinogenesis in heavier patients with liver cirrhosis.

Muto Y, Sato S, Watanabe A, Moriwaki H, Suzuki K, Kato A, Kato M, Nakamura T, Higuchi K, Nishiguchi S, Kumada H, Ohashi Y; Long-Term Survival Study (LOTUS) Group. Muto Y, et al. Among authors: kumada h. Hepatol Res. 2006 Jul;35(3):204-14. doi: 10.1016/j.hepres.2006.04.007. Epub 2006 Jun 5. Hepatol Res. 2006. PMID: 16737844

6

Diabetes mellitus increases the risk of hepatocarcinogenesis in patients with alcoholic cirrhosis: A preliminary report.

Torisu Y, Ikeda K, Kobayashi M, Hosaka T, Sezaki H, Akuta N, Kawamura Y, Yatsuji H, Suzuki F, Suzuki Y, Arase Y, Kumada H. Torisu Y, et al. Among authors: kumada h. Hepatol Res. 2007 Jul;37(7):517-23. doi: 10.1111/j.1872-034X.2007.00077.x. Hepatol Res. 2007. PMID: 17539994

7

Guidelines for the antiviral therapy of hepatitis C virus carriers with normal serum aminotransferase based on platelet counts.

Okanoue T, Itoh Y, Minami M, Hashimoto H, Yasui K, Yotsuyanagi H, Takehara T, Kumada T, Tanaka E, Nishiguchi S, Izumi N, Sata M, Onji M, Yamada G, Okita K, Kumada H. Okanoue T, et al. Among authors: kumada t, kumada h. Hepatol Res. 2008 Jan;38(1):27-36. doi: 10.1111/j.1872-034X.2007.00217.x. Hepatol Res. 2008. PMID: 18039201

8

Development of HCC in patients receiving adefovir dipivoxil for lamivudine-resistant hepatitis B virus mutants.

Hosaka T, Suzuki F, Kobayashi M, Hirakawa M, Kawamura Y, Yastuji H, Sezaki H, Akuta N, Suzuki Y, Saitoh S, Arase Y, Ikeda K, Miyakawa Y, Kumada H. Hosaka T, et al. Among authors: kumada h. Hepatol Res. 2010 Feb;40(2):145-52. doi: 10.1111/j.1872-034X.2009.00582.x. Epub 2009 Sep 25. Hepatol Res. 2010. PMID: 19788684

9

Correlation of YMDD mutation and breakthrough hepatitis with hepatitis B virus DNA and serum ALT during lamivudine treatment.

Kobayashi M, Suzuki F, Akuta N, Yatsuji H, Hosaka T, Sezaki H, Kobayashi M, Kawamura Y, Suzuki Y, Arase Y, Ikeda K, Mineta R, Iwasaki S, Watahiki S, Kumada H. Kobayashi M, et al. Among authors: kumada h. Hepatol Res. 2010 Feb;40(2):125-34. doi: 10.1111/j.1872-034X.2009.00565.x. Epub 2009 Sep 25. Hepatol Res. 2010. PMID: 19788696

10

Guidelines for the treatment of chronic hepatitis and cirrhosis due to hepatitis B virus infection for the fiscal year 2008 in Japan.

Kumada H, Okanoue T, Onji M, Moriwaki H, Izumi N, Tanaka E, Chayama K, Sakisaka S, Takehara T, Oketani M, Suzuki F, Toyota J, Nomura H, Yoshioka K, Seike M, Yotsuyanagi H, Ueno Y; Study Group for the Standardization of Treatment of Viral Hepatitis Including Cirrhosis, Ministry of Health, Labor and Welfare of Japan. Kumada H, et al. Hepatol Res. 2010 Jan;40(1):1-7. doi: 10.1111/j.1872-034X.2009.00633.x. Hepatol Res. 2010. PMID: 20156295

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

806 results

Search Page

Filters